Dose–response correlation for CAR-T cells: a systematic review of clinical studies

The potential of chimeric antigen receptor (CAR) T cells to successfully treat hematological cancers is widely recognized. Multiple CAR-T cell therapies are currently under clinical development, with most in early stage, during which dose selection is a key goal. The objective of this review is to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotte, Anand, Frigault, Matthew J, Ansari, Ayub, Gliner, Brad, Heery, Christopher, Shah, Bijal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791395/
https://www.ncbi.nlm.nih.gov/pubmed/36549782
http://dx.doi.org/10.1136/jitc-2022-005678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791395/
https://www.ncbi.nlm.nih.gov/pubmed/36549782
http://dx.doi.org/10.1136/jitc-2022-005678

Ejemplares similares